Alexander Pym is an Investigator at AHRI (African Health Research Institute) in Durban, South Africa. He was trained in Clinical Medicine, Infectious Diseases, Microbiology and Mycobacterial Genetics and has completed his PhD research at the Institute Pasteur, Paris followed by Post-doctoral studies at Stanford University. He has a broad research experience and has published on Esx secretion systems, recombinant TB vaccines and population genetics of M. tuberculosis. He subsequently worked in South Africa on clinical drug development of Bedaquiline in MDR-TB patients.   Alexander Pym is an Investigator at AHRI (African Health Research Institute) in Durban, South Africa. He was trained in Clinical Medicine, Infectious Diseases, Microbiology and Mycobacterial Genetics and has completed his PhD research at the Institute Pasteur, Paris followed by Post-doctoral studies at Stanford University. He has a broad research experience and has published on Esx secretion systems, recombinant TB vaccines and population genetics of M. tuberculosis. He subsequently worked in South Africa on clinical drug development of Bedaquiline in MDR-TB patients.  

clinical microbiology,virology